Optimization of autoclave cycles and selection of formulation for parenteral products, Part II: Effect of counter-ion on pH and stability of diatrizoic acid at autoclave temperatures.
D003973:Diatrizoate / Q000031:analogs & derivatives* / Q000378:metabolism*; D003974:Diatrizoate Meglumine / Q000378:metabolism*; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007700:Kinetics; D013242:Sterilization / Q000295:instrumentation*; D013696:Temperature
D003973:Diatrizoate; D003974:Diatrizoate Meglumine